MaxCyte, Inc. announced that Ron Holtz, who served as MaxCyte's CFO from 2005 until September 2020 and again since May 2022, having served as Chief Accounting Officer during the interim period, will take on the role of EVP, Administration for the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
375 GBX | 0.00% | +1.35% | +6.38% |
May. 08 | MaxCyte Shares Rise Sharply After Q1 Results Beat | MT |
May. 08 | MaxCyte shares rise amid double-digit revenue increase | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.38% | 497M | |
+11.82% | 228B | |
+14.36% | 196B | |
+17.76% | 141B | |
+28.40% | 110B | |
+0.53% | 65.88B | |
+16.50% | 54.3B | |
+6.33% | 52.39B | |
+11.23% | 45.22B | |
+4.99% | 37.12B |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MaxCyte, Inc. Appoints Ron Holtz as EVP, Administration